DNA methyltransferase 1 may be a therapy target for attenuating diabetic nephropathy and podocyte injury

DNA methyltransferase 1 may be a therapy target for attenuating diabetic nephropathy and podocyte injury is a paper indexed in ScholarIQ from OpenAlex.

How many citations does DNA methyltransferase 1 may be a therapy target for attenuating diabetic nephropathy and podocyte injury have?

DNA methyltransferase 1 may be a therapy target for attenuating diabetic nephropathy and podocyte injury has 103 citations in the OpenAlex counts ScholarIQ stores.

When was DNA methyltransferase 1 may be a therapy target for attenuating diabetic nephropathy and podocyte injury published?

DNA methyltransferase 1 may be a therapy target for attenuating diabetic nephropathy and podocyte injury has 2017 year in the ScholarIQ index.

What is the open-access status of DNA methyltransferase 1 may be a therapy target for attenuating diabetic nephropathy and podocyte injury?

DNA methyltransferase 1 may be a therapy target for attenuating diabetic nephropathy and podocyte injury has bronze oa status in the ScholarIQ index.

What is the DOI of DNA methyltransferase 1 may be a therapy target for attenuating diabetic nephropathy and podocyte injury?

The DOI for DNA methyltransferase 1 may be a therapy target for attenuating diabetic nephropathy and podocyte injury is on the source record.

What is the PMID of DNA methyltransferase 1 may be a therapy target for attenuating diabetic nephropathy and podocyte injury?

The PMID for DNA methyltransferase 1 may be a therapy target for attenuating diabetic nephropathy and podocyte injury is on the source record.

What is the OpenAlex record for DNA methyltransferase 1 may be a therapy target for attenuating diabetic nephropathy and podocyte injury?

The OpenAlex for DNA methyltransferase 1 may be a therapy target for attenuating diabetic nephropathy and podocyte injury is on the source record.